Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study

We studied the effects of treatment with olmesartan/amlodipine and olmesartan/hydrochlorothiazide on inflammatory and metabolic parameters (including new-onset diabetes as a secondary endpoint) in non-diabetic hypertensive patients with metabolic syndrome (MetS). A total of 120 patients with MetS an...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-Martin, F J, Rodriguez-Rosas, H, Peiro-Martinez, I, Soriano-Perera, P, Pedrianes-Martin, P, Comi-Diaz, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099035/
https://www.ncbi.nlm.nih.gov/pubmed/21107432
http://dx.doi.org/10.1038/jhh.2010.104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099035/
https://www.ncbi.nlm.nih.gov/pubmed/21107432
http://dx.doi.org/10.1038/jhh.2010.104

Ejemplares similares